Health and Fitness Health and Fitness
Tue, October 16, 2012
Mon, October 15, 2012
Sun, October 14, 2012
Fri, October 12, 2012
Thu, October 11, 2012
Wed, October 10, 2012
Tue, October 9, 2012
Mon, October 8, 2012
Sun, October 7, 2012
Sat, October 6, 2012
Fri, October 5, 2012
Thu, October 4, 2012
Wed, October 3, 2012
Tue, October 2, 2012
Mon, October 1, 2012
Sun, September 30, 2012
Sat, September 29, 2012
Fri, September 28, 2012

ZELTIQ®; Aesthetics to Showcase CoolCurve+ Applicator at IMCAS Asia Hong Kong 2012


//health-fitness.news-articles.net/content/2012/ .. rve-applicator-at-imcas-asia-hong-kong-2012.html
Published in Health and Fitness on Wednesday, October 3rd 2012 at 19:02 GMT by Market Wire   Print publication without navigation


--([ ])--ZELTIQ Aesthetics, Inc. (Nasdaq: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced Henry H. Chan, MD, PhD, FRCP, will perform a live demonstration of CoolCurve+, the newest addition to the applicator platform for the CoolSculpting System, at the International Master Course on Aging Skin (IMCAS) Asia in Hong Kong on October 5, 2012. Developed for enhanced fit and tissue draw, the anatomically curved shape of the CoolCurve+ applicator allows physicians to treat a multitude of body shapes.

WHAT:

Session 22 a" Lasers, Lights, Energy-Based Devices
Live CoolSculpting Demonstration with CoolCurve+ Applicator

WHEN:

Friday, October 5, 10:10-10:30 a.m.

WHERE:

International Master Course on Aging Skin (IMCAS) Asia
InterContinental Hong Kong Hotel
18 Salisbury Road, Kowloon, Hong Kong SAR
Room 3

WHO:

Henry H. Chan, MD, PhD, FRCP

For more information about CoolCurve+ and CoolSculpting, visit ZELTIQ Aesthetics at Booth B08. Exhibition hours are as follows: Friday, October 5, 8:30 a.m. to 6 p.m.; Saturday, October 6, 8:30 a.m. to 2 p.m.

About ZELTIQ Aesthetics, Inc.

ZELTIQ Aesthetics, Inc. (Nasdaq: ZLTQ) is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQas first commercial product, the CoolSculpting System, is designed to selectively reduce stubborn fat bulges that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. CoolSculpting utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer within a treated fat bulge without requiring the patient to diet or exercise.


Publication Contributing Sources